Publications by authors named "Chengyin Yu"

Claim this Profile
A
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics of BGT-002, a Novel ATP-Citrate Lyase Inhibitor, in Healthy Chinese Subjects.
Yun Liu, Chengyin Yu, Yifan Zhang, Zhifu Xie, Yating Wang, Liyu Liang, Chen Yu

Drug Des Devel Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mass balance, metabolism, and pharmacokinetics of [C]amdizalisib, a clinical-stage novel oral selective PI3Kδ inhibitor for the treatment of non-hodgkin's lymphoma, in healthy Chinese volunteers.
Chun-Yang Zhao, Li-Jun Zhang, Chan Sun, Cheng-Yin Yu, Jian Wang

Front Pharmacol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Drug-Drug Interaction Between Henagliflozin and Hydrochlorothiazide in Healthy Chinese Volunteers.
Qian Chen, Chengyin Yu, Qingqing Wu, Rong Song, Ye Liu, Chen Yu

Drug Des Devel Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics, and food effect of sudapyridine (WX-081), a novel anti-tuberculosis candidate in healthy Chinese subjects.
Chengyin Yu, Hongjie Qian, Qingqing Wu, Yang Zou, Qicheng Ding, Yuting Cai, Liyu Liang, Yun Liu

Clin Transl Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SYS6006, as a fourth-dose booster following three doses of inactivated vaccines in healthy adults: an open-labeled Phase 1 trial.
Yuzhou Gui, Ye Cao, Jiajin He, Chunyang Zhao, Wei Zheng, Chengyin Yu, Chen Yu

Life Metab· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and pharmacokinetics of fluoropezil (DC20), a novel acetylcholinesterase inhibitor: A phase I study in healthy young and elderly Chinese subjects.
Hongjie Qian, Chengyin Yu, Huijuan Zhu, Qichen Ding, Yuting Cai, Yun Liu

Clin Transl Sci· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SW-BIC-213, as a heterologous booster in healthy adults: an open-labeled, two-centered and multi-arm randomised, phase 1 trial.
Yu-Zhou Gui, Xue-Ning Li, Jing-Xin Li, Ming-Yun Shen, Mei-Wei Zhang, Li-Yu Liang, Cheng-Yin Yu, Chen Yu

EBioMedicine· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, mass balance, and metabolism of [C]TPN171, a novel PDE5 inhibitor, in humans for the treatment of pulmonary arterial hypertension.
Yi-Fei He, Yin Liu, Jing-Hua Yu, Huan Cheng, Abdullajon Odilov, Cheng-Yin Yu, Chen Yu

Acta Pharmacol Sin· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a ligand-binding assay for quantification of the F(ab') antivenom of Daboia russelii siamensis in human serum and its application to a phase I clinical study.
Yuzhou Gui, Chengyin Yu, Jiaye Zhou, Liang Xin, Ze Chen

J Pharm Biomed Anal· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomics analysis reveals a potential new target protein for the lipid-lowering effect of Berberine8998.
Cheng-Yin Yu, Gang-Yi Liu, Xiao-Hui Liu, Yu-Zhou Gui, Hai-Ming Liu, Chen Yu

Acta Pharmacol Sin· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
Yuzhou Gui, Sheng Yao, Hong Yan, Liang Hu, Chengyin Yu

Cardiovasc Res· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a liquid chromatography-isotope dilution tandem mass spectrometry for determination of olanzapine in human plasma and its application to bioavailability study.
Meng-Qi Zhang, Jing-Ying Jia, Chuan Lu, Gang-Yi Liu, Cheng-Yin Yu, Yu-Zhou Gui, Yun Liu, Chen Yu

Yao Xue Xue Bao· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic study of melamine in rhesus monkey after a single oral administration of a tolerable daily intake dose.
Gangyi Liu, Shuijun Li, Jingying Jia, Chengyin Yu, Jian He, Chen Yu

Regul Toxicol Pharmacol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of melamine and cyanuric acid in human urine by a liquid chromatography tandem mass spectrometry.
Mengqi Zhang, Shuijun Li, Chengyin Yu, Gangyi Liu, Jingying Jia, Chen Yu

J Chromatogr B Analyt Technol Biomed Life Sci· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis